A new model for reimbursing genome-based cancer care

Oncologist. 2014 Jan;19(1):1-4. doi: 10.1634/theoncologist.2013-0392. Epub 2013 Dec 5.

Abstract

Molecularly targeted medicine poses substantial challenges for incorporation into the existing U.S. health care system. It is argued here that performance-based risk-sharing arrangements may be a promising approach to address the competing needs of patients, clinicians, and payers.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Genome, Human
  • Genomics / economics
  • Genomics / methods
  • Humans
  • Models, Economic*
  • Neoplasms / economics
  • Neoplasms / genetics*
  • Neoplasms / therapy*
  • Reimbursement, Incentive*
  • Risk Sharing, Financial*
  • United States